Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The TOUCH Project: Reducing Distress and Promoting Quality of Life Via Caregiver Massage of Children Undergoing Treatment for Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01053494
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:53.354331+00:00
Published At
2018-07-02T00:00:00+00:00
Record Updated At
2018-07-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Accelerated Phase Chronic Myelogenous Leukemia", "Acute Undifferentiated Leukemia", "Angioimmunoblastic T-cell Lymphoma", "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative", "Blastic Phase Chronic Myelogenous Leukemia", "Burkitt Lymphoma", "Childhood Acute Lymphoblastic Leukemia in Remission", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Chronic Myelogenous Leukemia", "Childhood Diffuse Large Cell Lymphoma", "Childhood Grade III Lymphomatoid Granulomatosis", "Childhood Immunoblastic Large Cell Lymphoma", "Childhood Myelodysplastic Syndromes", "Childhood Nasal Type Extranodal NK/T-cell Lymphoma", "Chronic Eosinophilic Leukemia", "Chronic Myelomonocytic Leukemia", "Chronic Neutrophilic Leukemia", "Chronic Phase Chronic Myelogenous Leukemia", "Contiguous Stage II Mantle Cell Lymphoma", "Cutaneous B-cell Non-Hodgkin Lymphoma", "Essential Thrombocythemia", "Extramedullary Plasmacytoma", "Intraocular Lymphoma", "Isolated Plasmacytoma of Bone", "Juvenile Myelomonocytic Leukemia", "Mast Cell Leukemia", "Meningeal Chronic Myelogenous Leukemia", "Noncontiguous Stage II Mantle Cell Lymphoma", "Polycythemia Vera", "Post-transplant Lymphoproliferative Disorder", "Primary Myelofibrosis", "Primary Systemic Amyloidosis", "Progressive Hairy Cell Leukemia, Initial Treatment", "Prolymphocytic Leukemia", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Anaplastic Large Cell Lymphoma", "Recurrent Childhood Grade III Lymphomatoid Granulomatosis", "Recurrent Childhood Large Cell Lymphoma", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Small Noncleaved Cell Lymphoma", "Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma", "Recurrent Mycosis Fungoides/Sezary Syndrome", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Hairy Cell Leukemia", "Refractory Multiple Myeloma", "Relapsing Chronic Myelogenous Leukemia", "Secondary Acute Myeloid Leukemia", "Stage 0 Chronic Lymphocytic Leukemia", "Stage I Childhood Anaplastic Large Cell Lymphoma", "Stage I Childhood Hodgkin Lymphoma", "Stage I Childhood Large Cell Lymphoma", "Stage I Childhood Lymphoblastic Lymphoma", "Stage I Childhood Small Noncleaved Cell Lymphoma", "Stage I Chronic Lymphocytic Leukemia", "Stage I Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage I Multiple Myeloma", "Stage I Mycosis Fungoides/Sezary Syndrome", "Stage II Childhood Anaplastic Large Cell Lymphoma", "Stage II Childhood Hodgkin Lymphoma", "Stage II Childhood Large Cell Lymphoma", "Stage II Childhood Lymphoblastic Lymphoma", "Stage II Childhood Small Noncleaved Cell Lymphoma", "Stage II Chronic Lymphocytic Leukemia", "Stage II Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage II Multiple Myeloma", "Stage II Mycosis Fungoides/Sezary Syndrome", "Stage III Childhood Anaplastic Large Cell Lymphoma", "Stage III Childhood Hodgkin Lymphoma", "Stage III Childhood Large Cell Lymphoma", "Stage III Childhood Lymphoblastic Lymphoma", "Stage III Childhood Small Noncleaved Cell Lymphoma", "Stage III Chronic Lymphocytic Leukemia", "Stage III Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage III Multiple Myeloma", "Stage III Mycosis Fungoides/Sezary Syndrome", "Stage IV Childhood Anaplastic Large Cell Lymphoma", "Stage IV Childhood Hodgkin Lymphoma", "Stage IV Childhood Large Cell Lymphoma", "Stage IV Childhood Lymphoblastic Lymphoma", "Stage IV Childhood Small Noncleaved Cell Lymphoma", "Stage IV Chronic Lymphocytic Leukemia", "Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IV Mycosis Fungoides/Sezary Syndrome", "T-cell Large Granular Lymphocyte Leukemia", "Unspecified Childhood Solid Tumor, Protocol Specific"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-07-02"
protocolSection.identificationModule.nctId
"NCT01053494"
protocolSection.identificationModule.officialTitle
"The TOUCH Project: Reducing Distress and Promoting Quality of Life Via Caregiver Massage of Children Undergoing Treatment for Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Accelerated Phase Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Undifferentiated Leukemia (protocolSection.conditionsModule.conditions)
  • Angioimmunoblastic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative (protocolSection.conditionsModule.conditions)
  • Blastic Phase Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Acute Lymphoblastic Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Childhood Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Childhood Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Grade III Lymphomatoid Granulomatosis (protocolSection.conditionsModule.conditions)
  • Childhood Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Childhood Nasal Type Extranodal NK/T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Chronic Eosinophilic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Neutrophilic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Phase Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Cutaneous B-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Essential Thrombocythemia (protocolSection.conditionsModule.conditions)
  • Extramedullary Plasmacytoma (protocolSection.conditionsModule.conditions)
  • Intraocular Lymphoma (protocolSection.conditionsModule.conditions)
  • Isolated Plasmacytoma of Bone (protocolSection.conditionsModule.conditions)
  • Juvenile Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Mast Cell Leukemia (protocolSection.conditionsModule.conditions)
  • Meningeal Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Polycythemia Vera (protocolSection.conditionsModule.conditions)
  • Post-transplant Lymphoproliferative Disorder (protocolSection.conditionsModule.conditions)
  • Primary Myelofibrosis (protocolSection.conditionsModule.conditions)
  • Primary Systemic Amyloidosis (protocolSection.conditionsModule.conditions)
  • Progressive Hairy Cell Leukemia, Initial Treatment (protocolSection.conditionsModule.conditions)
  • Prolymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Grade III Lymphomatoid Granulomatosis (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Small Noncleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Recurrent/Refractory Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Hairy Cell Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Relapsing Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Secondary Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Stage 0 Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage I Childhood Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Childhood Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Childhood Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Childhood Small Noncleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage I Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Stage I Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage II Childhood Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Childhood Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Childhood Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Childhood Small Noncleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage II Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Stage II Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage III Childhood Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Childhood Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Childhood Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Childhood Small Noncleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage III Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Stage III Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IV Childhood Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Childhood Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Childhood Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Childhood Small Noncleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • T-cell Large Granular Lymphocyte Leukemia (protocolSection.conditionsModule.conditions)
  • Unspecified Childhood Solid Tumor, Protocol Specific (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.